Mounjaro is primarily used as a treatment for people with type 2 diabetes, in combination with dietary changes and exercise
Eli Lilly priced FOUNDAYO comparably to the WEGOVY pill, with self-pay access starting at $149/month for the lowest dose, eligible commercial insurance patients paying as low as $25/month with savings cards, and Medicare Part D patients expected to access it for $50/month beginning July 1, 2026
Any extra B12 that you consume will be eliminated by your kidneys and in your urine
Coverage for GLP-1 medications varies significantly across Canada
Compound clear cell sarcoma of the skina potential diagnostic pitfall: report of a series of 4 new cases and a review of the literature
Weight changes in Parkinsons are often multifactorial reduced intake, swallowing impairment, and disease-related metabolic changes all play a role and therefore require a truly multidisciplinary approach.